My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 113

    1.

    Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina.

    Kurihara T, Ozawa Y, Nagai N, Shinoda K, Noda K, Imamura Y, Tsubota K, Okano H, Oike Y, Ishida S.

    Diabetes. 2008 Aug;57(8):2191-8. Epub 2008 May 16.PMID: 18487452 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Neuroprotective effects of angiotensin II type 1 receptor (AT1R) blocker, telmisartan, via modulating AT1R and AT2R signaling in retinal inflammation.

    Kurihara T, Ozawa Y, Shinoda K, Nagai N, Inoue M, Oike Y, Tsubota K, Ishida S, Okano H.

    Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5545-52.PMID: 17122147 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.

    Nagai N, Izumi-Nagai K, Oike Y, Koto T, Satofuka S, Ozawa Y, Yamashiro K, Inoue M, Tsubota K, Umezawa K, Ishida S.

    Invest Ophthalmol Vis Sci. 2007 Sep;48(9):4342-50.PMID: 17724226 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    (Pro)renin receptor-mediated signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal inflammation.

    Satofuka S, Ichihara A, Nagai N, Noda K, Ozawa Y, Fukamizu A, Tsubota K, Itoh H, Oike Y, Ishida S.

    Diabetes. 2009 Jul;58(7):1625-33. Epub 2009 Apr 23.PMID: 19389828 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1/2 signaling.

    Anandanadesan R, Gong Q, Chipitsyna G, Witkiewicz A, Yeo CJ, Arafat HA.

    J Gastrointest Surg. 2008 Jan;12(1):57-66. Epub 2007 Nov 17.PMID: 18026817 [PubMed - indexed for MEDLINE]Related articles

    6.

    Angiotensin II and endothelin-1 augment the vascular complications of diabetes via JAK2 activation.

    Banes-Berceli AK, Ketsawatsomkron P, Ogbi S, Patel B, Pollock DM, Marrero MB.

    Am J Physiol Heart Circ Physiol. 2007 Aug;293(2):H1291-9. Epub 2007 May 25.PMID: 17526654 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Plasma kallikrein mediates angiotensin II type 1 receptor-stimulated retinal vascular permeability.

    Phipps JA, Clermont AC, Sinha S, Chilcote TJ, Bursell SE, Feener EP.

    Hypertension. 2009 Feb;53(2):175-81. Epub 2009 Jan 5.PMID: 19124682 [PubMed - indexed for MEDLINE]Related articles

    8.

    Novel regulatory effect of angiotensin II type 1 receptor-interacting molecule on vascular smooth muscle cells.

    Azuma K, Tamura K, Shigenaga A, Wakui H, Masuda S, Tsurumi-Ikeya Y, Tanaka Y, Sakai M, Matsuda M, Hashimoto T, Ishigami T, Lopez-Ilasaca M, Umemura S.

    Hypertension. 2007 Nov;50(5):926-32. Epub 2007 Sep 17.PMID: 17875818 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Inhibition of corneal neovascularization by blocking the angiotensin II type 1 receptor.

    Usui T, Sugisaki K, Iriyama A, Yokoo S, Yamagami S, Nagai N, Ishida S, Amano S.

    Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4370-6.PMID: 18829859 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    [Expression of angiotensin II type 1 receptor in cervical squamous cell carcinoma and its clinical significance]

    Liao YD, Xu H, Han Q, Lei J, Zhang YY, Wang ZH.

    Zhonghua Zhong Liu Za Zhi. 2007 May;29(5):360-4. Chinese. PMID: 17892132 [PubMed - indexed for MEDLINE]Related articles

    11.

    Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor gamma.

    Imayama I, Ichiki T, Inanaga K, Ohtsubo H, Fukuyama K, Ono H, Hashiguchi Y, Sunagawa K.

    Cardiovasc Res. 2006 Oct 1;72(1):184-90. Epub 2006 Jul 21.PMID: 16938288 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Angiotensin II type 1 receptor blocker attenuates the activation of ERK and NADPH oxidase by mechanical strain in mesangial cells in the absence of angiotensin II.

    Yatabe J, Sanada H, Yatabe MS, Hashimoto S, Yoneda M, Felder RA, Jose PA, Watanabe T.

    Am J Physiol Renal Physiol. 2009 May;296(5):F1052-60. Epub 2009 Mar 4.PMID: 19261744 [PubMed - indexed for MEDLINE]Related articles

    13.

    Telmisartan, an angiotensin II type 1 receptor antagonist, attenuates T-type Ca2+ channel expression in neonatal rat cardiomyocytes.

    Morishima M, Wang Y, Akiyoshi Y, Miyamoto S, Ono K.

    Eur J Pharmacol. 2009 May 1;609(1-3):105-12. Epub 2009 Mar 16.PMID: 19292980 [PubMed - indexed for MEDLINE]Related articles

    14.

    Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis.

    Ihara Y, Egashira K, Nakano K, Ohtani K, Kubo M, Koga J, Iwai M, Horiuchi M, Gang Z, Yamagishi S, Sunagawa K.

    J Mol Cell Cardiol. 2007 Oct;43(4):455-64. Epub 2007 Jul 21.PMID: 17761193 [PubMed - indexed for MEDLINE]Related articles

    15.

    Angiotensin II regulation of TGF-beta in murine mesangial cells involves both PI3 kinase and MAP kinase.

    Perlman A, Lawsin LM, Kolachana P, Saji M, Moore J Jr, Ringel MD.

    Ann Clin Lab Sci. 2004 Summer;34(3):277-86.PMID: 15487702 [PubMed - indexed for MEDLINE]Related articles

    16.

    Valsartan regulates the interaction of angiotensin II type 1 receptor and endothelial nitric oxide synthase via Src/PI3K/Akt signalling.

    Su KH, Tsai JY, Kou YR, Chiang AN, Hsiao SH, Wu YL, Hou HH, Pan CC, Shyue SK, Lee TS.

    Cardiovasc Res. 2009 Jun 1;82(3):468-75. Epub 2009 Mar 23.PMID: 19307231 [PubMed - indexed for MEDLINE]Related articles

    17.

    (Pro)renin receptor promotes choroidal neovascularization by activating its signal transduction and tissue renin-angiotensin system.

    Satofuka S, Ichihara A, Nagai N, Noda K, Ozawa Y, Fukamizu A, Tsubota K, Itoh H, Oike Y, Ishida S.

    Am J Pathol. 2008 Dec;173(6):1911-8. Epub 2008 Oct 30.PMID: 18974301 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination.

    Suganuma T, Ino K, Shibata K, Kajiyama H, Nagasaka T, Mizutani S, Kikkawa F.

    Clin Cancer Res. 2005 Apr 1;11(7):2686-94.PMID: 15814650 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Renal nitric oxide production is decreased in diabetic rats and improved by AT1 receptor blockade.

    Awad AS, Webb RL, Carey RM, Siragy HM.

    J Hypertens. 2004 Aug;22(8):1571-7.PMID: 15257181 [PubMed - indexed for MEDLINE]Related articles

    20.

    Diabetic state, high plasma insulin and angiotensin II combine to augment endothelin-1-induced vasoconstriction via ETA receptors and ERK.

    Kobayashi T, Nogami T, Taguchi K, Matsumoto T, Kamata K.

    Br J Pharmacol. 2008 Dec;155(7):974-83. Epub 2008 Aug 18.PMID: 19029977 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity